Yuta Takashima - Concepedia

Author

Yuta Takashima

Hokkaido University ORCID

Also Known As

Takashima, Yuta, Y Takashima, Y. Takashima, Yuta Takashima

Publications

283

Citations

H-Index

Concepts

All Affiliations

Hokkaido University Sapporo Medical University Hokkaido University Hospital Shinshu University Obihiro Kosei General Hospital

About

Yuta Takashima is an author at Hokkaido University specializing in medicine, lung cancer, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	102
2	Cell Biology	3	3	79
3	Immunology	3	3	54
4	Pathology	2	2	71
5	Cancer Cell Biology	1	1	15

Yuta Takashima

Publications

243

Citations

H-Index

Page 1

	Year	Citations
<scp>DLL</scp>3 regulates the migration and invasion of small cell lung cancer by modulating Snail Megumi Furuta, Hajime Kikuchi, Tetsuaki Shoji, Cancer Science	2019	78
A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer Hiroyuki Yasuda, Eiki Ichihara, Jun Sakakibara‐Konishi, Lung Cancer Phase I/ii StudyMedicinePathologyBronchial NeoplasmCancer Genetics	2021	48
Bromodomain and extraterminal domain inhibition synergizes with WEE1‐inhibitor AZD1775 effect by impairing nonhomologous end joining and enhancing DNA damage in nonsmall cell lung cancer Yuta Takashima, Eiki Kikuchi, Junko Kikuchi, International Journal of Cancer	2019	34
Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study Ryo Ko, Takehito Shukuya, Yusuke Okuma, The Oncologist	2018	29
Clinicopathologic Features and Immune Microenvironment of Non–Small-cell Lung Cancer With Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Yuta Takashima, Jun Sakakibara‐Konishi, Yutaka Hatanaka, Clinical Lung Cancer Non–small-cell Lung CancerCancer ImmunosurveillanceImmune MicroenvironmentMedicineImmunology	2018	23
Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer Tetsuaki Shoji, Eiki Kikuchi, Junko Kikuchi, Cancer Chemotherapy and Pharmacology Potential Therapeutic TargetCisplatin-resistant Small CellMedicineImmunologyImmune Checkpoint Inhibitor	2020	16
<scp>EGFR</scp> inhibition in <scp>EGFR</scp>‐mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment Akihiko Shiiya, Takuro Noguchi, Utano Tomaru, Cancer Science Lung InflammationImmunologyKinase InhibitorsCfdna MonitoringImmunotherapy	2022	15

Page 1